CNS Pharmaceuticals logo
CNS Pharmaceuticals CNSP
$ 2.75 0.0%

Annual report 2025
added 03-31-2026

report update icon

CNS Pharmaceuticals Historical Prices 2011-2026 | CNSP

Annual Historical Prices CNS Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.39 1.36 0.35 1.13 0.601 1.72 4.31 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.31 0.35 1.69

Historical Prices of other stocks in the Biotechnology industry

Issuer Historical Prices Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
18.2 - 2.43 % $ 254 M germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
0.58 $ 3.97 6.43 % $ 9.55 B australiaAustralia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.86 - - $ 86.2 M usaUSA
Akouos Akouos
AKUS
5.34 - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
0.68 - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
9.78 - 4.14 % $ 49.1 M usaUSA
Genfit SA Genfit SA
GNFT
3.36 - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
0.33 - -13.47 % $ 169 M franceFrance
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
0.12 $ 5.12 11.55 % $ 345 B britainBritain
Aligos Therapeutics Aligos Therapeutics
ALGS
6.67 $ 7.66 3.23 % $ 75.7 M usaUSA
Allakos Allakos
ALLK
1.31 - - $ 28.6 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
311 $ 320.13 -3.98 % $ 41.9 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
0.29 - -18.52 % $ 27.3 M britainBritain
Applied Molecular Transport Applied Molecular Transport
AMTI
0.57 - - $ 10.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
26.7 $ 21.81 0.6 % $ 1.02 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
10.6 $ 4.67 -1.37 % $ 766 M britainBritain
Applied Therapeutics Applied Therapeutics
APLT
6.42 - - $ 8.42 M usaUSA
BioNTech SE BioNTech SE
BNTX
91.2 $ 102.12 2.66 % $ 27.2 B germanyGermany
Aptinyx Aptinyx
APTX
0.14 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
1.66 - -13.39 % $ 1.45 M usaUSA
Advaxis Advaxis
ADXS
0.31 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
5.72 - 5.93 % $ 314 M canadaCanada
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.92 $ 3.08 -4.94 % $ 5.07 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
13 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
1.3 $ 1.35 -12.9 % $ 347 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
0.5 - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.3 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
4.37 $ 4.26 0.47 % $ 456 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
74.2 - - $ 96.9 B britainBritain
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
27.1 $ 24.19 -1.59 % $ 3.08 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.17 - 1.93 % $ 17.4 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
1.26 - -2.5 % $ 5.88 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
3.1 - -4.8 % $ 255 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
1.21 $ 1.61 8.05 % $ 428 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
3.32 - -45.71 % $ 1.2 M canadaCanada
AVROBIO AVROBIO
AVRO
1.27 - 1083.1 % $ 745 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
185 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
0.61 - - $ 546 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
48.4 - - $ 3.67 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
19.3 - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
23.4 - - $ 1.41 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
1.26 $ 1.07 1.9 % $ 13.1 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
2.82 $ 3.52 3.53 % $ 354 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
32.3 - - $ 3.45 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
0.383 - 3.16 % $ 1.9 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
5.67 - -0.88 % $ 598 M usaUSA